Results 11 to 20 of about 305,145 (241)

Mucosal melanoma – diagnostic challenge

open access: yesPrzegląd Dermatologiczny
Mucosal melanoma malignum (mMM) is a rare and aggressive malignancy that carries a poor prognosis. Most commonly, it develops on the mucous membranes in the head and neck region, and within the genitalia. Because of its anatomical location and absence of
Paulina Karp   +2 more
doaj   +2 more sources

Concurrent Mucosal Melanoma and Angiofibroma of the Nose [PDF]

open access: yesClinical and Experimental Otorhinolaryngology, 2016
Malignant melanoma rarely develops in the paranasal sinuses, and generally has a poor prognosis. However, mucosal melanoma can masquerade both clinically and histopathologically as a benign lesion, rendering accurate early diagnosis difficult.
Jae Hyung Hwang   +3 more
doaj   +2 more sources

Multidisciplinary approach and treatment of acral and mucosal melanoma [PDF]

open access: yesFrontiers in Oncology
Acral and mucosal melanoma are uncommon variants of melanoma. Acral melanoma has an age-adjusted incidence of approximately 1.8 cases per million individuals per year, accounting for about 2% to 3% of all melanoma cases.
Ana Fortuna   +2 more
doaj   +3 more sources

Primary Intranasal Melanotic Mucosal Melanoma – A Case Report and Literature Review

open access: yesInternational Medical Case Reports Journal
Samson Dires Gashaw, Waltengus Demissie Birhanu, Fitsum Alemayehu Department of Otolaryngology, Head and Neck Surgery, St. Paul’s Hospital Millennium Medical College, Addis Ababa, EthiopiaCorrespondence: Waltengus Demissie Birhanu, Email waltebirh@gmail ...
Gashaw SD, Birhanu WD, Alemayehu F
doaj   +1 more source

Mucosal Melanoma In Situ of the Oral Cavity: A Case Report and Systematic Review of the Literature [PDF]

open access: yes, 2022
Objective:Malignant mucosal melanomas of the head and neck comprise a very small portion of all melanomas, particularly in the oral cavity. These lesions are associated with high rates of local recurrence, distant metastasis, and a very poor 5-year ...
Jim Howell   +13 more
core   +1 more source

Time-varying pattern of recurrence risk for localized melanoma in China

open access: yesWorld Journal of Surgical Oncology, 2020
Background Acral and mucosal melanomas are rarely seen in Caucasians but common in China. There are limited data on the recurrence characteristics for these patients.
Xizhi Wen   +9 more
doaj   +1 more source

Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy

open access: yesScientific Reports, 2022
Limited studies have interrogated the genomic landscape of Chinese melanoma in which acral and mucosal melanoma are the mainstay. In this study, we carried out a retrospective analysis on 81 Chinese melanoma patients (15 acral, 25 mucosal and 41 ...
Fuxue Huang   +9 more
doaj   +1 more source

Mucosal Melanoma of Eustachian Tube: A Case Report

open access: yes, 2022
Mucosal melanoma originating from the eustachian tube is very rare, and only 15 cases were reported so far. In this study, we report a case of mucosal melanoma from the eustachian tube which was surgically managed, followed by chemoradiotherapy.
Sang Duk Hong   +7 more
core   +1 more source

A rare case of primary mucosal melanoma involving the oropharynx

open access: yes, 2021
: Melanomas are malignant tumors arising from melanocytes. A vast majority of melanomas occur on cutaneous surfaces. Rarely, melanomas can also be found in various extracutaneous sites where melanocytes are scarcely present.
G. Van Haesendonck   +17 more
core   +1 more source

Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy

open access: yesCase Reports in Oncology, 2020
Since the incidence of mucosal melanoma is higher in the Japanese population compared to Caucasians, and since mucosal melanoma possesses a lower mutation burden compared to cutaneous melanoma, the efficacy of anti-PD1 antibody (Ab) monotherapy for ...
Taku Fujimura   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy